Levels of cytokine receptor activator of nuclear factor κB ligand in gingival crevicular fluid in untreated chronic periodontitis patients

Journal of Periodontology

Volumn 75, Issue 12, 2004, Pages 1586-1591

  Vernal, Rolando ^a   Chaparro, Alejandra ^a   Graumann, Rebecca ^a   Puente, Javier ^a   Valenzuela, Maria Antonieta ^a   Gamonal, Jorge ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b Facultad de Odontologia   (Chile)

Author keywords

Alveolar bone loss diagnosis; Gingival crevicular fluid chemistry; Receptor activator, nuclear factor kappa B analysis

Indexed keywords

CYTOKINE; OSTEOCLAST DIFFERENTIATION FACTOR;

ADULT; ARTICLE; BONE REMODELING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; MALE; OSTEOCLAST; OSTEOLYSIS; PATIENT MONITORING; PERIODONTITIS; TISSUE INJURY;

ADULT; AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NF-KAPPA B; OSTEOCLASTS; PERIODONTITIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STATISTICS, NONPARAMETRIC;

EID: 13844307928     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.12.1586     Document Type: Article

References (35)

1. Armitage G. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
2. Listgarten MA. Pathogenesis of periodontitis. J Clin Periodontol 1986;13:418-430.
3. Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss and mammalian evolution. Annu Rev Immunol 2002;20:795-823.
4. Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997; 390:175-179.
5. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
6. Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cell. J Biol Chem 1997;272:190-194.
7. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci (USA) 1998;95:3597-3602.
8. Lum L, Wong BR, Josien R, et al. Evidence for a role of a tumor necrosis factor-α (TNF-α)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 1999; 274:13613-13618.
9. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999;402:304-309.
10. Teng YT, Nguyen H, Gao X, et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000;106:59-67.
11. Haffajee AD, Socransky SS, Goodson JM. Comparision of different data analysis for detection changes in attachment levels. J Clin Periodontol 1983;10:298-310.
12. Chung RM, Grbic JT, Lamster IB. Interleukin-8 and beta-glucuronidase in gingival crevicular fluid. J Clin Periodontol 1997;24:146-152.
13. Nakagawa N, Kinosaki M, Yamaguchi K, et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 1998;253:395-400.
14. Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JMW. Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 1999;25:525-534.
15. Zappa U, Reinking-Zappa M, Graf H, Espeland M. Cell populations and episodic periodontal attachment loss in humans. J Clin Periodontol 1991;18:508-515.
16. Jeffcoat MJ, Reddy MS. Progression of probing attachment loss in adult periodontitis. J Periodontol 1991;62:185-189.
17. Zappa U, Simona C, Schappi P, Graf H, Espeland M. Episodic probing attachment loss in human histiologic association. J Periodontol 1990;61:420-426.
18. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-1514.
19. Kong YY, Penninger JM. Molecular control of bone remodeling and osteoporosis. Exp Gerontol 2000;35:947-956.
20. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and function of helper T cells. Adv Immunol 1989;46:111-147.
21. Ishikawa I, Nakashima K, Koseki T, et al. Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000 1997;14:79-111.
22. Fujihashi KM, Yamamoto M, Hiroi T, Bamberg TV, McGhee JR, Kiyono H. Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues. Clin Exp Immunol 1996;103:422-428.
23. Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontitis. J Immunol 2000;164:2103-2109.
24. Takeichi O, Haber J, Kawai T, Smith DJ, Moro I, Taubman MA. Cytokine profile of T lymphocytes from gingival tissues with pathological pocketing. J Dent Res 1994;79: 1548-1555.
25. Teng YT. Mixed periodontal Th1-Th2 cytokine profile in Actinobacillus actinomycetemcomitans-specific osteoprotegerin ligand (or RANK-L)-mediated alveolar bone destruction in vivo. Infect Immun 2002;70:5269-5273.
26. Gemmel E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004;35:21-41.
27. Nakashima K, Giannopoulou C, Andersen E, et al. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol 1996;23:832-838.
28. McCauley LK, Nohutcu RM. Mediators of periodontal osseous destruction and remodeling: Principles and implications for diagnosis and therapy. J Periodontol 2002; 73:1377-1391.
29. Gamonal J, Bascones A, Jorge O, Silva A. Levels of interleukin-1β, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult patients with destructive periodontitis and the effect of periodontal treatment. J Periodontol 2000; 71:1535-1545.
30. Gamonal J, Bascones A, Jorge O, Silva A. Chemokine RANTES in gingival crevicular fluid of adult patients with periodontitis. J Clin Periodontol 2000;27:675-681.
31. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic test. Ann Periodontol 1997;2:123-137.
32. Lossdörfer S, Götz W, Jäger A. Immunohistochemical localization of receptor activator of nuclear factor kappa (RANK) and its ligand (RANKL) in human deciduous teeth. Calcif Tissue Int 2002;71:45-52.
33. Crotti T, Smith MD, Hirsch R, et al. Receptor activator NF kappa B ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380-387.
34. Liu D, Xu JK, Figliomeni L, et al. Expression of RANKL and OPG mRNA in periodontal disease: Possible involvement in bone destruction. Int J Mol Med 2003;11: 17-21.
35. Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83: 166-169.